ARTICLES ON VALVULOPATHIES
Treatment of asymptomatic valve disease: now it is mitral regurgitation’s turn
A multicentre study emulating a clinical trial examines the association between early mitral valve surgery and survival in patients with asymptomatic severe primary mitral regurgitation and preserved left ventricular function.
Is it time to update follow-up strategies after TAVI?
This review highlights the strengths of computed tomography in the early assessment after TAVI, particularly for detecting subclinical leaflet thrombosis, and proposes an algorithm for adjusting antithrombotic treatment according to imaging findings.
Should annular enlargement be considered in all patients with aortic stenosis and a small annulus?
An anatomical perspective on the technique and outcomes of aortic root enlargement during surgical aortic valve replacement according to Bo Yang’s group.
Beyond the operating room: what can twenty years of experience in ischemic mitral regurgitation teach us?
Original article comparing long-term survival according to residual mitral regurgitation, completeness of revascularization, and ventricular remodeling among patients undergoing mitral valve repair with restrictive annuloplasty and concomitant coronary artery bypass grafting for chronic ischemic mitral regurgitation, based on two decades of single-center follow-up.
Can a new robot-assisted mitral valve surgery program achieve excellence from its earliest cases?
Retrospective analysis presenting a single-center experience with the first 100 cases of a robotic mitral valve program
Early aortic valve replacement: is prevention better than cure?
Long-term results of the RECOVERY trial on the management of severe aortic stenosis in asymptomatic patients.
Perceval® prostheses and sex: similar outcomes, but are they truly equivalent? A critical appraisal from the largest published single-center experience
Prospective multicenter registry and meta-regression assessing outcomes after Perceval Plus® implantation according to sex. The findings support comparable early safety in men and women, although several limitations preclude concluding true equivalence.
Trends in aortic valve replacement among patients aged 65 years and younger in the United States
Retrospective observational study based on a nationwide administrative database, aimed at describing contemporary trends in the use of TAVR, surgical bioprosthetic valves, and mechanical valves among patients aged 40 to 65 years undergoing isolated aortic valve replacement in the United States.
TAVR vs isolated SAVR in low-risk patients: 5-year comparative outcomes from the Evolut Low Risk trial
Post hoc subanalysis of the Evolut Low Risk trial comparing 5-year outcomes in 1164 low-risk patients with severe aortic stenosis undergoing isolated aortic valve replacement, either transcatheter (TAVR) or surgical (SAVR).
Beyond TAVI: what the 2025 valvular heart disease guidelines change for cardiac surgeons
A surgeons’ notebook article summarizing the main surgical implications of the 2025 ESC/EACTS guidelines on valvular heart disease and exploring how these recommendations may be translated into daily clinical practice.